Monogram Biosciences, Inc. (CIK: 0001094961) EDGAR, Information, Filings... CompaniesBIO.Com

Monogram Biosciences, Inc.

Mailing address
345 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, Delaware, 94080
Phone
650.635.1100
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

Monogram Biosciences, Inc. (CIK: 0001094961) is an American company incorporated in the state of California. Head office is located at 345 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, California, 94080. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. Monogram Biosciences, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

VIROLOGIC INC from 2000-17-Apr to 2005-01-Sep

Owner	Filings	Transaction Date	Type of Owner
LABORATORY CORP OF AMERICA HOLDINGS	0000920148	Aug-04-2009	10 percent owner
SIEBEL KENNETH F	0001390436	Sep-29-2008	10 percent owner
White Christine Anna	0001371859	Aug-20-2008	director
Parry Gordon	0001428162	Feb-22-2008	officer: VP, Oncology Research & Dvlp.
Wray Patricia	0001375182	Mar-29-2007	officer: VP, Human Resources
BARUCH THOMAS R	0001005563	Apr-07-2006	director
JENKINS WILLIAM J	0001111157	Apr-07-2006	director
KEPNER CRISTINA	0001189847	Apr-07-2006	director
MERRIWEATHER ALFRED G	0001211839	Apr-07-2006	officer: VP Finance & CFO
YOUNG WILLIAM D	0001217420	Apr-07-2006	director, officer: Chairman & CEO
DUNN MICHAEL JOHN	0001231091	Apr-07-2006	officer: Chief Business Officer
WELCH WILLIAM J	0001237522	Apr-07-2006	officer: SVP & Chief Commercial Officer
MENDLEIN JOHN	0001238362	Apr-07-2006	director
PERSING DAVID H	0001263113	Apr-07-2006	director
BUI TIEN T	0001267486	Apr-07-2006	officer: VP Sales
HIBBS KATHY L	0001267487	Apr-07-2006	officer: VP General Counsel
PETROPOULOS CHRISTOS J	0001267488	Apr-07-2006	officer: VP Virology & Chief Scientific
WHITECOMB JEANNETTE	0001267489	Apr-07-2006	officer: VP Operations
JENNINGS EDMON R	0001267491	Apr-07-2006	director
HITCHNER KENNETH N	0001267584	Apr-07-2006	officer: VP Pharm Collaborations
BATES MICHAEL P	0001294273	Apr-07-2006	officer: VP Clinical Research
SINGH SHARAT	0001211845	Dec-16-2004	officer: CTO, Oncology
WILSON KAREN J	0001267490	Mar-17-2004	officer: Vice President, CFO
BB BIOTECH AG	0000924223	Dec-29-2003	10 percent owner
BIOTECH GROWTH N V	0001259869	Dec-29-2003	10 percent owner
BIOTECH TARGET N V	0001259870	Dec-29-2003	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Monogram Biosciences, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001144204-09-051819 (34 Act) Size: 64 KB	Oct-07-2009	005-59123 091109083
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-09-051816 ( Act) Size: 6 KB	Oct-06-2009
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001318148-09-001300 (34 Act) Size: 129 KB	Sep-10-2009	005-59123 091062179
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-09-180321 (34 Act) Size: 9 KB	Aug-24-2009	000-30369 091031164
RW	Document	Registration Withdrawal Request Acc-no: 0001193125-09-179686 (NE Act) Size: 6 KB	Aug-21-2009	333-157294 091028470
RW	Document	Registration Withdrawal Request Acc-no: 0001193125-09-179685 (NE Act) Size: 6 KB	Aug-21-2009	333-157294 091028465
EFFECT	Document	Acc-no: 9999999995-09-002330 (33 Act) Size: 2 KB	Aug-20-2009	333-137350 091027529
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-09-178265 (33 Act) Size: 17 KB	Aug-19-2009	333-137350 091024328
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-09-178263 (33 Act) Size: 16 KB	Aug-19-2009	333-137351 091024312
EFFECT	Document	Acc-no: 9999999995-09-002319 (33 Act) Size: 2 KB	Aug-18-2009	333-65716 091022760
EFFECT	Document	Acc-no: 9999999995-09-002314 (33 Act) Size: 2 KB	Aug-18-2009	333-141193 091022759
EFFECT	Document	Acc-no: 9999999995-09-002308 (33 Act) Size: 2 KB	Aug-18-2009	333-121475 091022755
EFFECT	Document	Acc-no: 9999999995-09-002307 (33 Act) Size: 2 KB	Aug-18-2009	333-121438 091022752
EFFECT	Document	Acc-no: 9999999995-09-002321 (33 Act) Size: 2 KB	Aug-18-2009	333-86892 091022749
EFFECT	Document	Acc-no: 9999999995-09-002320 (33 Act) Size: 2 KB	Aug-18-2009	333-70562 091022748
EFFECT	Document	Acc-no: 9999999995-09-002311 (33 Act) Size: 2 KB	Aug-18-2009	333-135096 091022745
EFFECT	Document	Acc-no: 9999999995-09-002304 (33 Act) Size: 2 KB	Aug-18-2009	333-103980 091022743
EFFECT	Document	Acc-no: 9999999995-09-002303 (33 Act) Size: 2 KB	Aug-18-2009	333-102995 091022742
EFFECT	Document	Acc-no: 9999999995-09-002302 (33 Act) Size: 2 KB	Aug-18-2009	333-102273 091022744
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-09-176849 (33 Act) Size: 17 KB	Aug-17-2009	333-141193 091020024

Recent 20 filings. View all Monogram Biosciences, Inc. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Monogram Biosciences, Inc. overview
Monogram Biosciences, Inc. job
Monogram Biosciences, Inc. stock
Monogram Biosciences, Inc. ownership
Monogram Biosciences, Inc. CEO
Monogram Biosciences, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.